The companies want to utilize Precision’s BCI platform and Medtronic’s wide-ranging Neuroscience portfolio. Together, they plan to co-develop an integrated solution that combines Precision’s Layer 7 cortical interface with the Medtronic StealthStation surgical navigation system.
Precision develops an ultra-thin cortical electrode array enabling BCI technology that aims to address paralysis. The Layer 7 thin-film brain-computer interface (BCI) features 1,024 electrodes embedded in a flexible film. This film conforms to the brain surface. It comes in at one-fifth the thickness of a human hair. This device aims to help users with severe paralysis operate digital devices, like computers and smartphones, using their thoughts.
The New York-based company won FDA clearance for Layer 7 in April. It provided a leg up in the BCI market for Precision. It continues to challenge the likes of Neuralink, Synchron and others in the growing space.
Medtronic designed its StealthStation technology as a surgical navigation system that precisely locates anatomical structures in open or percutaneous neurosurgical and spine procedures.
Commentary from Precision Neuroscience and Medtronic officials
Michael Mager, CEO of Precision Neuroscience, said:
“Our work with Medtronic represents an important step toward advancing how the field understands and interacts with the human brain. Precision’s minimally invasive approach allows this technology to reach widespread clinical use, opening the door to new insights and breakthroughs. Partnering with Medtronic accelerates that path— Medtronic’s Cranial & Spinal Technologies business provides ubiquitous and trusted platforms in neurosurgery, and integrating our technology into a tool surgeons already rely on represents a step change in how quickly we can bring these capabilities into everyday practice.”
Brett Wall, EVP and president of Medtronic’s Neuroscience Portfolio, said:
“At Medtronic, we believe the brain is the next frontier in medicine. For more than 30 years, our products and therapies have improved the lives of patients with neurological conditions. Today, we’re learning more about the brain than ever before. By integrating Precision Neuroscience’s advanced brain mapping technology with our trusted cranial and spinal technology, we’re exploring the future of cranial surgery and accelerating the global adoption of adaptive, intelligent therapies. These kinds of partnerships are not about chasing trends—it’s about delivering real, meaningful breakthroughs for patients and setting new standards for neurological care worldwide.”
